Testing effectiveness (Phase 2)Study completedNCT01005251
What this trial is testing
Investigate the Effect of Different Doses of Lesogaberan (AZD3355) as add-on to PPI in GERD Patients With Partial Response to PPI
Who this might be right for
Gastroesophageal Reflux DiseaseHeartburnRegurgitation
AstraZeneca 661